Variable | All | NO hypertension | Hypertension | P value |
---|---|---|---|---|
N = 1085 | N = 554 | N = 531 | ||
Age (year) | 65.58 (51.75–78.05) | 59.49 (45.06–75.84) | 72.04 (59.54–79.38) |  < 0.001 |
Sex (male), n (%) | 609 (56.13%) | 323 (58.30%) | 286 (53.86%) | 0.140 |
Systolic BP-max (mmHg) | 181.00 (162.00–201.00) | 175.00 (157.00–197.00) | 185.00 (167.00–204.50) |  < 0.001 |
Systolic BP-min (mmHg) | 84.50 (0.00–99.00) | 82.50 (0.00–97.00) | 86.00 (0.00–99.00) | 0.315 |
Diastolic BP-max (mmHg) | 97.00 (84.00–117.00) | 96.00 (82.25–115.00) | 99.00 (85.00–119.50) | 0.089 |
Diastolic BP-min (mmHg) | 40.00 (0.00–48.00) | 40.00 (0.00–49.00) | 40.00 (0.00–48.00) | 0.291 |
Race | Â | Â | Â | 0.017 |
    Asian, n (%) | 26 (2.40%) | 7 (1.26%) | 19 (3.58%) | |
    Black, n (%) | 61 (5.62%) | 24 (4.33%) | 37 (6.97%) | |
    White, n (%) | 758 (69.86%) | 395 (71.30%) | 363 (68.36%) | |
    Other, n (%) | 240 (22.12%) | 128 (23.10%) | 112 (21.09%) | |
Insurance |  |  |  |  < 0.001 |
    Government, n (%) | 35 (3.23%) | 24 (4.33%) | 11 (2.07%) | |
    Medicaid, n (%) | 92 (8.48%) | 46 (8.30%) | 46 (8.66%) | |
    Medicare, n (%) | 513 (47.28%) | 209 (37.73%) | 304 (57.25%) | |
    Private, n (%) | 415 (38.25%) | 251 (45.31%) | 164 (30.89%) | |
    Self Pay, n (%) | 30 (2.76%) | 24 (4.33%) | 6 (1.13%) | |
Firts Careunit |  |  |  |  < 0.001 |
    CCU, n (%) | 30 (2.76%) | 11 (1.99%) | 19 (3.58%) | |
    CSRU, n (%) | 70 (6.45%) | 46 (8.30%) | 24 (4.52%) | |
    MICU, n (%) | 175 (16.13%) | 87 (15.70%) | 88 (16.57%) | |
    SICU, n (%) | 470 (43.32%) | 202 (36.46%) | 268 (50.47%) | |
    TSICU, n (%) | 340 (31.34%) | 208 (37.55%) | 132 (24.86%) | |
Traumatic hemorrhage |  |  |  |  < 0.001 |
    NO trauma, n (%) | 698 (64.33%) | 310 (55.96%) | 388 (73.07%) | |
    Trauma, n (%) | 387 (35.67%) | 244 (44.04%) | 143 (26.93%) | |
Type of cerebral hemorrhage |  |  |  |  < 0.001 |
    Extradural hemorrhage, n (%) | 3 (0.28%) | 1 (0.18%) | 2 (0.38%) | |
    Intracranial hemorrhage, n (%) | 475 (43.78%) | 210 (37.91%) | 265 (49.91%) | |
    Subdural hemorrhage, n (%) | 230 (21.20%) | 121 (21.84%) | 109 (20.53%) | |
    Subarachnoid hemorrhage, n (%) | 341 (31.43%) | 191 (34.48%) | 150 (28.25%) | |
    Multiple hemorrhage, n (%) | 36 (3.32%) | 31 (5.60%) | 5 (0.94%) | |
Comorbidities | ||||
 Heart failure, n (%) | 139 (12.81%) | 70 (12.64%) | 69 (12.99%) | 0.860 |
 Myocardial infarct, n (%) | 18 (1.66%) | 14 (2.53%) | 4 (0.75%) | 0.022 |
 Malignant, n (%) | 36 (3.32%) | 26 (4.69%) | 10 (1.88%) | 0.010 |
 Cerebral infarction, n (%) | 57 (5.25%) | 25 (4.51%) | 32 (6.03%) | 0.264 |
 Diabetes, n (%) | 10 (0.92%) | 6 (1.08%) | 4 (0.75%) | 0.570 |
 Chronic kidney disease, n (%) | 11 (1.01%) | 9 (1.62%) | 2 (0.38%) | 0.040 |
Blood parameters | ||||
 Glucose-max (mg/dL) | 178.00 (147.00–219.00) | 175.00 (145.00–216.00) | 182.00 (151.50–225.50) | 0.011 |
 Glucose-min (mg/dL) | 93.00 (81.00–107.00) | 92.00 (80.00–104.00) | 95.00 (83.00–110.00) | 0.001 |
 PTT-max (sec) | 30.20 (26.80–36.90) | 30.95 (27.20–39.80) | 29.60 (26.70–34.60) |  < 0.001 |
 PTT-min (sec) | 24.60 (22.70–26.70) | 24.55 (22.60–26.80) | 24.60 (22.80–26.55) | 0.730 |
 PT-max (sec) | 13.90 (13.20–15.40) | 14.10 (13.30–15.60) | 13.80 (13.10–15.00) | 0.003 |
 PT-min (sec) | 12.60 (12.10–13.10) | 12.50 (12.10–13.00) | 12.60 (12.10–13.10) | 0.338 |
 INR PT-max | 1.30 (1.20–1.50) | 1.30 (1.20–1.50) | 1.20 (1.10–1.50) |  < 0.001 |
 INR PT-min | 1.10 (1.00–1.10) | 1.10 (1.00–1.10) | 1.10 (1.00–1.10) | 0.427 |
 RBC-max (m/uL) | 4.10 (3.74–4.45) | 4.09 (3.73–4.43) | 4.12 (3.76–4.48) | 0.408 |
 RBC-min (m/uL) | 3.16 (2.80–3.64) | 3.09 (2.70–3.57) | 3.24 (2.89–3.68) |  < 0.001 |
 Platelet count-max (K/uL) | 313.00 (230.00–449.00) | 311.00 (226.00–461.75) | 313.00 (230.50–440.00) | 0.974 |
 Platelet count-min (K/uL) | 172.00 (122.00–218.00) | 162.00 (109.25–211.00) | 180.00 (134.00–224.00) |  < 0.001 |
 WBC-max (K/uL) | 14.90 (11.90–19.00) | 15.55 (12.22–19.97) | 14.30 (11.55–18.10) |  < 0.001 |
 WBC-min (K/uL) | 7.70 (5.90–9.90) | 7.60 (5.80–9.60) | 7.90 (6.20–10.20) | 0.078 |
Mortality | ||||
 1-month mortality, n (%) | 324 (29.86%) | 166 (29.96%) | 158 (29.76%) | 0.940 |
 1-year mortality, n (%) | 413 (38.06%) | 214 (38.63%) | 199 (37.48%) | 0.696 |